Physician profile
Werner Martens
NPI 1669534871
$862.53
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.36 · 2020: $107 · 2021: $354 · 2022: $138 · 2023: $91.72 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $447.80 | 2019-2023 | Rybelsus, Ozempic |
| Pfizer INC. | $103.95 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $76.73 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $51.67 | 2019-2025 | Spravato |
| Novartis Pharmaceuticals Corporation | $45.85 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $34.87 | 2025 | Uptravi, Opsumit |
| Corcept Therapeutics | $23.48 | 2025 | Korlym |
| Abbott Laboratories | $22.99 | 2022 | |
| Daiichi Sankyo INC. | $21.90 | 2021 | |
| Medtronic, INC. | $21.17 | 2025 | Inceptiv |
| Lilly USA, LLC | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Werner Martens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.